Showing results (61-70 of 97) with videos related to
Sort By:
Pageof 10
International Journal of Molecular Sciences|October 26, 2024
Single-Nuclei Transcriptome Profiling Reveals Intra-Tumoral Heterogeneity and Characterizes Tumor Microenvironment Architecture in a Murine Melanoma ModelSushant Parab, Valery Sarlo, Sonia Capellero, et al.Cancers|April 30, 2021
Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung CancerVanesa Gregorc, Chiara Lazzari, Mario Mandalá, et al.European Journal of Internal Medicine|August 15, 2021
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case seriesCorrado Campochiaro, Nicola Farina, Alessandro Tomelleri, et al.Antibiotics (Basel, Switzerland)|September 28, 2023
Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case SeriesBianca Maria Longo, Francesco Venuti, Alberto Gaviraghi, et al.Tumori|August 19, 2008
Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic TumorsVienna Ludovini, Lorenza Pistola, Vanesa Gregorc, et al.Frontiers in Oncology|April 30, 2025
Validation of machine learning-based models to predict and explain the risk of ovarian cancer: a multicentric study on BRCA-mutated patients undergoing risk-reducing salpingo-oophorectomyVera Loizzi, Maria Colomba Comes, Francesca Arezzo, et al.Cancer|July 2, 2003
Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational StudyFederico Cappuzzo, Giovanni Selvaggi, Vanesa Gregorc, et al.Journal of the National Cancer Institute|August 5, 2004
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancerFederico Cappuzzo, Elisabetta Magrini, Giovanni Luca Ceresoli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2005
Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patientsFederico Cappuzzo, Marileila Varella-Garcia, Hisayuki Shigematsu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncologyVienna Ludovini, Lorenza Pistola, Vanesa Gregorc, et al.Pageof 10